Change
Tools:
Print this page Compare to last year's report

Consolidated statement of income


3rd quarter

 

January - September

2010

2011

in € millions

2010

2011

 

 

 

 

 

 

 

Continuing operations

 

 

3,867

4,051

Revenue

11,020

11,910

(2,277)

(2,511)

Cost of sales

(6,442)

(7,247)

1,590

1,540

Gross profit

4,578

4,663

(853)

(857)

Selling expenses

(2,484)

(2,539)

(275)

(293)

General and administrative expenses

(789)

(887)

(89)

(87)

Research and development expenses

(251)

(258)

8

(2)

Other operating income/(expenses)

6

27

381

301

Operating income

1,060

1,006

(70)

(70)

Net financing expenses

(271)

(197)

9

9

Results from associates and joint ventures

21

24

320

240

Profit before tax

810

833

(81)

(74)

Income tax

(210)

(246)

239

166

Profit for the period from continuing operations

600

587

 

 

 

 

 

 

 

Discontinued operations

 

 

21

1

Profit for the period from discontinued operations

58

14

260

167

Profit for the period

658

601

 

 

 

 

 

 

 

Attributable to

 

 

238

149

Shareholders of the company

592

545

22

18

Non-controlling interests

66

56

260

167

Profit for the period

658

601

Copyright © 2011 Akzo Nobel N.V.